top of page
Ideas

CONNECTING IDEAS TO OPPORTUNITIES
Find the researchers, assets and partners your pipeline needs, before your competitors do.

OniX Hub helps biotech, pharma, universities and foundations see the global research landscape and act on it. Use our AI agents yourself, or let our team do the searching.

Look Everywhere. No one can see you.

OniX Research Agent. Private AI research intelligence that runs on your own Mac: grants, papers, trials, tech transfer and startups in one search.

Two ways to work with us

Same data, same expertise. You choose how hands-on you want to be.

Do it yourself
 

The OniX Research Agent: scored results with a plain reason, a private Library, reports, and everything stays on your computer.

We do it for you

​

Our team scouts, maps and reports, and introduces you to the right people.

Our reach

Grants, papers, trials, startups and technologies. One search.

1M+

Research Funding

200M+

Publications

600K+

Clinical Trials

15K+

Tech transfer

50K+

Startup companies

Who we serve
Three distinct challenges, one precision partner

 

Pharma/VC & Biotech BD Teams

Precision scouting of emerging researchers across any disease area — oncology, rare disease, CNS, cardiometabolic, and more. Any geography, any funder. MoA-tagged, BD-ready.

​

​

Universities, Nonprofits and Foundations

Navigate today's funding disruption. Build industry partnerships, diversify revenue, access international grants, and find alternative pathways through our PIVOT program.

​

​

Veterinary & One Health

Cross-species innovation intelligence. Human-to-animal and animal-to-human pipeline translation. Veterinary BD scouting and partnership development.

​

​

Share your innovation

Researchers, startups and biotech innovators: submit a non-confidential abstract of your therapeutic idea, asset or product. An OniX expert reviews it personally, asks for more if needed, and can introduce you to partners aligned with your work.

OnPoint | PIVOT newsletter

Startups spotlight, VC funding news and breakthrough research, on Substack.

bottom of page